BRWCX
Price
$26.59
Change
-$0.30 (-1.12%)
Updated
Nov 18 closing price
Net Assets
505.29M
GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
Interact to see
Advertisement

BRWCX vs GFACX

Header iconBRWCX vs GFACX Comparison
Open Charts BRWCX vs GFACXBanner chart's image
MFS Blended Research Growth Eq C
Price$26.59
Change-$0.30 (-1.12%)
VolumeN/A
Net Assets505.29M
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
BRWCX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
BRWCX vs. GFACX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWCX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. BRWCX (505M). BRWCX (0.00) and GFACX (0.00) have matching dividends . BRWCX was incepted earlier than GFACX: BRWCX (10 years) vs GFACX (25 years). BRWCX (1.43) is less costly to investors than GFACX (1.36). BRWCX is a more actively managed with annual turnover of: 46.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than BRWCX: GFACX (250) vs BRWCX (1000). BRWCX annual gain was more profitable for investors over the last year : 9.79 vs. GFACX (5.07). BRWCX return over 5 years is better than : 46.30 vs. GFACX (24.08).
BRWCXGFACXBRWCX / GFACX
Total Expense Ratio1.391.36102%
Annual Report Gross Expense Ratio1.431.36105%
Fund Existence10 years25 years-
Gain YTD12.33614.44585%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets505M330B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.795.07193%
Returns for 3 years86.4654.86158%
Returns for 5 years46.3024.08192%
Returns for 10 years158.0869.66227%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP6.900.21
+3.13%
Fortress Biotech
TLPH1.340.02
+1.52%
Talphera
JANX29.020.30
+1.04%
Janux Therapeutics
MBAV10.580.01
+0.09%
M3 Brigade Acquisition V Corp.
CDE14.38-0.08
-0.55%
Coeur Mining